Macrophage Polarization States in the Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
The M1/M2 macrophage paradigm plays a key role in tumor progression. M1 macrophages are historically regarded as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis. The tumor microenvironment (TME) can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes. Investigating TME-induced macrophage polarization is critical for further understanding of TAM-related pro-tumor outcomes and potential development of new therapeutic approaches. This review explores the current understanding of TME-induced macrophage polarization and the role of M2-polarized macrophages in promoting tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21,22,23].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs express high levels of both iNOS and arginase-1, which both play a direct role in suppression of T-cell function [95].”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Inflammation can be triggered by conditions such as infection or injury or can be systemic as seen in type 2 diabetes and cardiovascular disease [59].”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 3×
“Current literature supports the theory that most TAMs originate from either tissueresident embryonic macrophages or macrophages derived from circulating monocytes that originate in the bone marrow [87].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 3×
“The significance of macrophage heterogeneity has been under review since the early 2000s and has been linked to many malignancies and autoimmune disorders in recent years [66].”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“The resolution of inflammation is led by the deactivation of these inflammatory mediators, permitting either the apoptosis of pro-inflammatory M1 macrophages or the transition to an anti-inflammatory M2 macrophage [64].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 15×
“Macrophages are found in every human tissue in the body and exhibit anatomical and functional diversity [4].”
BackgroundInfluentialMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · cited 2×
“Some noncytokine, extrinsic pathways of macrophage polarization do exist, however, including hypoxia as well as the production of lactate within tumors, which drive M2 polarization [36].”
BackgroundFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Cited by
Items 901–1,000 of 1,000
Wang, X., Yang, K., Yang, B. T., Wang, R., Zhu, Y., & Pan, T. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03930-z · Cited by 5
“Notably, TAMs are highly heterogeneous and plastic [9–11].”
Lai, G., Zhao, X., Chen, Y., Xie, T., Su, Z., Lin, J., Chen, K., & Chen, K. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114260 · Cited by 5
Li, S., Yin, X., Ren, W., Zheng, J., Li, S., Zhi, K., & Gao, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144342 · Cited by 5
Bhattacharya, P., Linnenbach, A. J., South, A. P., Martinez‐Outschoorn, U., Curry, J., Johnson, J. M., Harshyne, L. A., Mahoney, M. G., Luginbuhl, A., & Vadigepalli, R. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013127 · Cited by 6
Zhou, K., & Chen, R. (2025) · Discover Oncology · doi:10.1007/s12672-025-02996-0 · Cited by 5
“Additionally, the M2 macrophages present in the C1 group primarily contribute to anti-inflammatory and reparative processes, aiding in tissue repair and regeneration [39–41].”
Context Matters: Divergent Roles of Exercise-Induced and Tumor-Derived Lactate in Cancer
Hekmatikar, A. H. A., Zolfaghari, G., Basereh, A., Daud, D. M. A., & Khoramipour, K. (2025) · Biomolecules · doi:10.3390/biom15071010 · Cited by 7
“It promotes the polarization of macrophages to the M2-like TAM state at the expense of pro-inflammatory M1 macrophages [51].”
Aging and lung cancer: the role of macrophages
Yang, X., Gao, L., & Fu, D. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114676 · Cited by 7
Li, Z., Ma, J., Guan, H., Lai, J., Xu, F., & Cao, G. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10073-z · Cited by 5
“( 1234567890) (Boutilier and Elsawa 2021).”
Chen, S., Zhang, S., Shi, Y. K., & Liu, X. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003738 · Cited by 8
Prognostic and therapeutic relevance of IL2RG-related LncRNAs in clear cell renal cell carcinoma
Hu, W., Wu, B., Chen, Y., Guo, X., Wang, X., & Wang, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-15439-1 · Cited by 5
“For instance, while CD8 + T cells and M1 macrophages are typically associated with anti-tumor responses 60 their presence in the high-risk group might indicate an ongoing immune response in the tumor microenvironment, which could be suppressed or regulated by other factors.”
Cucurbitacin B in cancer: A comprehensive review of its targets and molecular mechanisms
Mi, L., He, T., Lei, D., Lei, D., Su, A., Wei, T., Li, Z., & Wu, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117240 · Cited by 6
Tang, H., Zhang, R., Xu, Y. X., Wang, X., Gu, J., Gu, L., & Liu, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-03459-2 · Cited by 5
“Hypoxia also promotes the accumulation of immune-suppressive cells like MDSCs and TAMs, which adopt a pro-tumor M2-like phenotype [13].”
Xu, Y., Lan, F., Yang, C., & Li, P. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07026-9 · Cited by 7
“M1 macrophages are typically regarded as anti-tumorigenic, while M2 macrophages are viewed as pro-tumorigenic [151].”
Lu, C. H., Liu, J., Chen, Z., Guo, B.-T., Dong, C.-S., Yu, H., Tang, X.-M., Liu, J., Ji, C., Tao, K., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01474-y · Cited by 7
“M2 is generally an anti-inflammatory and pro-cancerous MΦ type promoting tumor growth, proliferation and metastasis [209–211].”
Xiao, Z., Yuan, J., Wu, Q., Qin, J., Liu, Y., Zhang, S., Sun, B., Dai, R., Zhang, P., Shao, N., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.11.005 · Cited by 7
“This is due to their capacity to stimulate T-cell and natural killer cell (NK-cell) activation, thereby enhancing the overall immune response 44 .”
InfluentialChang, J., Zhao, H. Y., Tian, G., Cai, J., Chen, X., Tang, J., & Jia, G. (2026) · Animal nutrition · doi:10.1016/j.aninu.2025.11.008 · Cited by 6
Qiu, Y., Bi, H., Xie, W., Zhao, J., Zhang, T., Fu, J., Liu, X., & Li, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1779575 · Cited by 7
“This phenomenon, analogous to the Warburg effect observed in cancer cells, allows for the rapid, high-yield generation of energy and substrates within a short timeframe to meet the biosynthetic needs of activated macrophages (59, 60).”
Ren, H., Deng, Z., Lu, S., Zhang, J., Liu, W., & Tan, J. (2026) · Advanced Science · doi:10.1002/advs.202521183 · Cited by 5
“Analysis of tumor-associated macrophages (TAMs) [ 52 ] revealed that NP@Fla-Cu treatment skewed the polarization toward a pro-inflammatory M1 phenotype (F4/80 + CD80 + CD206 − ), increasing their proportion from 18.37% to 32.90%, while reducing the immunosuppressive M2 phenotype (F4/80 + CD80 −…”
InfluentialHu, K., Liu, S., Sheng, S., Zhang, S., Li, B., Sun, B., & Xia, A. (2026) · iLiver · doi:10.1016/j.iliver.2026.100234 · Cited by 6
“44,46 It is noteworthy that, in vitro , macrophage polarization is often defined along the classical (M1) and alternative (M2) pathways, which helps to identify cell states with pro-inflammatory or reparative functional tendencies.”
NLRP3+ macrophages aggravate inflammatory cystitis in diabetes
Peng, Y., & Gao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057746 · Cited by 5
“It is known that the phenotypic adaptations of macrophages during the interaction are dynamic and involve not only changes in major functionality (M1 versus M2), but also some delicate changes in certain function such as phagocytotic, regenerative or immune resolution (22).”
BackgroundLv, M., He, F., Guo, J., Zheng, Z., Wang, W., & Xie, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.999966 · Cited by 6
“It has been reported that extrinsic polarization, which is mediated by the cytokines, HIF1/2, and endothelin-2 secreted from other immune cells, was the primarymethod ofmacrophage polarization (Ivashkiv, 2020; Boutilier and Elsawa, 2021).”
BackgroundMethodInfluentialZhang, M.-L., Li, Z., Pei, W., Li, X., Yang, H., Zhu, X., & Lu, K. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.03.08 · Cited by 5
Lei, Y., He, J., & Tang, Y. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104102 · Cited by 5
Regulation of Macrophage Polarization in Allergy by Noncoding RNAs
Ishibashi, O., Muljo, S. A., & Islam, Z. (2023) · Non-Coding RNA · doi:10.3390/ncrna9060075 · Cited by 5
“This reaction involves critical physiological functions such as removing cancer cells that are generated in the body [31]; however, they can also cause pathological states such as autoimmune diseases [43,44].”
BackgroundResearch Progress of Nanomaterials Acting on NK Cells in Tumor Immunotherapy and Imaging
Feng, Y., Zhang, H., Shao, J., Du, C., Zhou, X., Guo, X., & Wang, Y. (2024) · Biology · doi:10.3390/biology13030153 · Cited by 7
KEAP1-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage Phenotype
Occhiuto, C. J., & Liby, K. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063510 · Cited by 6
“CD206 is a marker for polarization of M2-like macrophages [55] and increased abundance of these cells within the tumor microenvironment signifies poor lung cancer prognosis [56] and immunosuppression [55,57].”
BackgroundRAC1 as a potential pan-cancer diagnostic, prognostic, and immunological biomarker
Tao, L., Xu, X., Fang, Z., Christopoulos, P., Cortinovis, D. L., & Lu, Y. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2016 · Cited by 5
“…as anti-inflammatory cells, play a significant role in promoting various pro-tumorigenic effects in cancer, including regulation of angiogenesis and lymphangiogenesis, immune suppression, induction of hypoxia, promotion of tumor cell proliferation, and facilitation of metastasis (26,27).”
BackgroundMa, J., Tan, J., Zhang, W., Bai, M., & Liu, K. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03666-w · Cited by 5
“To realize their multiple functions, macrophages are polarized toward M1, which contribute to antitumor responses, or M2, which are relevant with tumor progression [8].”
BackgroundTeng, Y., & Liu, R. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2145 · Cited by 5
“M2 polarized macrophages facilitate tumor progression through various mechanisms and typically represent a pro-tumor cell type (20).”
A critical review on exploring tumor Microenvironment's impacts on radioresistance
Houshyari, M. (2024) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2024.100937 · Cited by 9
Zhong, X., Zhang, F., Xiao, H., & Tu, R. (2024) · Immunobiology · doi:10.1016/j.imbio.2024.152811 · Cited by 5
Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy
Reghu, G., Vemula, P. K., Bhat, S. G., & Narayanan, S. (2024) · Journal of Biosciences · doi:10.1007/s12038-024-00441-y · Cited by 8
“They can also interact with myeloid-derived suppressor cells (MDSCs) and suppress T cell-mediated anti-tumour responses (Parker et al. 2014; Boutilier and Elsawa 2021).”
InfluentialIwanaga, R., Yamamoto, T. M., Gomez, K., Nguyen, L. L., Woodruff, E. R., Post, M. D., Mikeska, R. G., Danis, E. P., Danhorn, T., Boorgula, M. P., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0027 · Cited by 5
“…tumor microenvironment (TME), M1 macrophages are proposed to be tumor-suppressive and M2 macrophages tumor-promoting; however, the expression of M1 and M2 protein markers is not mutually exclusive for each type and the complexity of this spectrum remains a significant focus in the field (39–41).”
BackgroundHU, M., Fang, Z., Shao, Y., Yan, J., & Ye, G. H. (2025) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.051589 · Cited by 6
“TAMs are derived from bone marrow monocytes which are the most prevalent immune cells in the TME [124].”
Gellert, J., Agardy, D. A., Kumar, S., Kourtesakis, A., Boschert, T., Jähne, K., Breckwoldt, M. O., Bunse, L., Wick, W., Davies, M. A., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0024 · Cited by 6
“…macrophage polarization states are highly dynamic and M1-like TAM readily acquire a M2-like phenotype when exposed to immune-suppressive cytokines like interleukin 4 (IL4), IL10, transforming growth factor β (TGF β ) and to hypoxia, conditions associated with tumor growth and progression (17).”
Chen, R., & Jiang, L. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2325 · Cited by 6
Wang, S., Gao, S., Lin, S., Fang, X., Zhang, H., Qiu, M., Zheng, K., Ji, Y., Xiao, B., & Zhang, X. (2024) · BMC Neurology · doi:10.1186/s12883-024-03924-5 · Cited by 5
Ivanova, D., Semkova, S., Grigorov, B., Tzanova, M. T., Georgieva, A., Danchev, D., Nikolova, B., & Yaneva, Z. L. (2025) · Molecules · doi:10.3390/molecules30020393 · Cited by 5
“Altered macrophage plasticity and polarization, normally communicating with the activation of the innate immune response, can contribute both to malignancy development and to tumor vascularization [64,69,70].”
Srisathaporn, S., Ekalaksananan, T., Heawchaiyaphum, C., Aromseree, S., Maranon, D. G., Altina, N. H., Nukpook, T., Wilusz, J., & Pientong, C. (2025) · Cancers · doi:10.3390/cancers17030491 · Cited by 7
“Research has demonstrated that IL-6 can stimulate both M1 and M2 pathways [103–105].”
Zhao, L., Zhang, Y., Wang, J., Li, D., & Hao, X. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.01.007 · Cited by 5
Unveiling the role of CXCL10 in pancreatic cancer progression: A novel prognostic indicator
Wu, X., Rong, L., Tang, R., Li, Q., Fei, W., Deng, X., & Miao, L. (2025) · Open Medicine · doi:10.1515/med-2024-1117 · Cited by 5
“Under the in fl uence of the complex tumor microenvironment, macrophages can be recruited to the tumor area to be polarized into the M1 state, inhibiting tumor growth or the M2 state and promoting tumor growth [14 – 16].”
Quercetin Inhibits Gastric Cancer Progression via FAM198B/MAPK Pathway Modulation
Deng, H., Xiao, Q., Xu, X., Zhang, L., & Zhang, Y. (2025) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s511324 · Cited by 7
“37 Correlation analysis involving immune checkpoints also revealed associations between FAM198B expression and immunosuppressive checkpoints that weaken antitumor immunity, particularly HAVCR2 and PDCD1LG2.”
Ma, D., Wang, Y., Shen, Q., Liu, X., Lu, W., Li, S., Yin, Q., Xia, L., Liu, G., Chen, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1567035 · Cited by 5
“During early tumor development, chemokines enrich antitumor M1 TAMs, which support antigen presentation, effector cell activation, and tumor immunity (26).”
Intracranial Virotherapy for a Canine Hemangioma
Delgado-Bonet, P., Tomeo-Martín, B. D., Delgado-Bonet, B., Sardón, D., Torrado-Carvajal, Á., Mateo, I., & Perisé-Barrios, A. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911677 · Cited by 5
“M1 macrophages (MAC387+) and activated microglia (Iba1+) have a proinflammatory behavior and trigger antitumoral responses; therefore, an increased number of these cells could favor a more immunoreactive TME [37].”
BackgroundLi, K., Yu, H., Bao, Z., Xu, L. X., Zhang, H., Wang, T., Yu, L., & Yuan, Y. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122384 · Cited by 5
Lipid Metabolic Regulatory Crosstalk Between Cancer Cells and Tumor-Associated Macrophages
Liu, S., Shen, Y., Yin, L., Liu, J., & Zu, X. (2023) · DNA and Cell Biology · doi:10.1089/dna.2023.0071 · Cited by 6
IL-12p40 Monomer: A Potential Player in Macrophage Regulation
Jeong, B. M., & Pahan, K. (2024) · Immuno · doi:10.3390/immuno4010005 · Cited by 5
Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs
Jung, M., & Bonavida, B. (2024) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2024053096 · Cited by 7
Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors
Gan, Q., Li, Y., Li, Y., Liu, H., Chen, D., Liu, L., & Peng, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1359914 · Cited by 6
“The versatility lies in their ability to adopt M1 or M2 phenotypes, or a blend of both, exerting nuanced effects on the tumor microenvironment (129, 130).”
BackgroundBalcioglu, H. E., Wijers, R., Smid, M., Hammerl, D., Trapman-Jansen, A., Oostvogels, A. A. M., Timmermans, M. A. M., Martens, J. W. M., & Debets, R. (2024) · npj Imaging · doi:10.1038/s44303-024-00022-6 · Cited by 7
“Shorter distances observedamong TAMs in longer survivors may suggest the presence of M1-like TAMs that may further support the anti-tumor activity of T cells 42,43 .”
Xu, Y., Hu, J., Cao, C., Zhang, M., Liu, Y., Chen, H., Wei, S., Zhu, Z., Yang, Y., Yu, L., et al. (2021) · Journal of Oncology · doi:10.1155/2021/2427427 · Cited by 5
Marek, K., Armando, F., Nippold, V. M., Röhn, K., Plattet, P., Brogden, G., Gerold, G., Baumgärtner, W., & Puff, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116156 · Cited by 5
“Classically activated macrophages (M1) are known to be pro-inflammatory and anti-tumoral, while alternatively activated macrophages (M2) behave contrarily [20,21].”
BackgroundThe significance of M1 macrophage should be highlighted in peripheral nerve regeneration.
Feng, R., & Zhang, P. (2023) · PubMed · doi:10.14670/hh-18-591 · Cited by 9
Wu, M. H., Zhang, S., Chi, C., Zhu, H., Ma, H., Liu, L., Shi, Q., Li, D., & Ju, X. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.05.003 · Cited by 7
Yanagi, M., Terasaki, M., Kiriyama, T., Terasaki, Y., Akatsuka, J., Endo, Y., Nishimura, T., Shimizu, A., & Kondo, Y. (2023) · Discover Oncology · doi:10.1007/s12672-023-00741-z · Cited by 5
“In general, M2 macrophage is associated with the growth of fibrous tissue and tumor growth/development [18].”
BackgroundZhang, W., Chen, L.-L., Yang, S., Zhong, Y., Lu, X. B., Wang, Y., Wang, Z., & Tu, Y. (2023) · Genomics · doi:10.1016/j.ygeno.2023.110702 · Cited by 5
Cai, H., Lin, Y., Wu, Y., Wang, Y., Li, S., Zhang, Y., Zhuang, J., Liu, X., & Guan, G. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28673 · Cited by 8
“Lastly, the levels of cytokines secreted by M2 macrophages across different risk scores were determined [27,28].”
BackgroundSCG2 Mediates HNSCC Progression With CCL2 / TGFβ1 high M2 Macrophage Infiltration
Miao, C., You, X., Zhang, Z., Jiang, Z., Liu, L., Jia, Y., Bai, J., Gao, Y., Ye, L., Cao, Y., et al. (2024) · Oral Diseases · doi:10.1111/odi.15154 · Cited by 5
Benderski, K., Schneider, P. M., Kordeves, P., Fichter, M., Schunke, J., Lorenzi, F. D., Durak, F., Schrörs, B., Akilli‐Öztürk, Ö., Kiessling, F. M., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107560 · Cited by 4
Kong, P., Ye, J., Sun, M., Zhou, Z., Zhang, Y., Yang, X., Ren, J., Yang, M., Dong, Y., & Song, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1507227 · Cited by 5
“Based on gene expression characteristics and functions, TAMs are usually categorized into M1 and M2 types, with M1 macrophages possessing anti-tumor functions, while M2 macrophages exhibit pro-tumor activities (6).”
Extracellular vesicles in the pathogenesis and future diagnostics of oral squamous cell carcinoma
Batur, A., Novak, R., Salai, G., Hrkač, S., Ćosić, V., & Grgurević, L. (2025) · Future Science OA · doi:10.1080/20565623.2025.2461940 · Cited by 4
“…between subtypes occur based on changes in cytokine and growth factor secretion or the presence of inflammation, infection, injury, hypoxia, etc. [33]. initially, the tM is characterized by a higher presence of M1 macrophages, but as cancer progresses, the number of M2-subtype macrophages…”
Role of IL ‐34 in Tumors and Its Application to Regulate Inflammation
Igarashi, Y., & Seino, K.-I. (2025) · Cancer Science · doi:10.1111/cas.70020 · Cited by 4
“Furthermore, TAMs induce regulatory T cells (Tregs) that suppress T-cell activity, thereby impairing tumor immunity [2, 3].”
Targeting macrophage to myofibroblast transition by circ_0001103 for subretinal fibrosis treatment
Zhang, Q., Lu, B., He, L., Fang, K., Zhu, X., Chen, T., Zhu, Y., Liu, Y., & Zhang, P. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06173-3 · Cited by 4
“In different microenvironments, macrophages can differentiate into different subtypes, and different subtypes of macrophages in turn play different roles in shaping the environment [29, 30].”
Xu, H., Ma, K., Ma, Z., Zhuang, T., & Lin, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1558903 · Cited by 5
“M1 and M2 macrophages can adjust their polarization according to the changes of the environment, and can transform into each other or depolarize (32, 33).”
Wang, Q., Deng, Y., Feng, Y., & Liu, Z. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04251-3 · Cited by 4
Han, F., Cheng, Y., Xu, X., Yin, J., & Zhang, W. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114621 · Cited by 4
Wang, Q., Ren, S., Zheng, P., Chen, Y., & Liu, X. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100061 · Cited by 4
Lee, C., Kim, K., Hyun, S., Hong, S., & Rhee, I. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118448 · Cited by 4
Chen, W., Liu, W., & Miao, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-17128-5 · Cited by 5
“Moreover, Monocytes, which differentiate into macrophages in the tumor microenvironment, can have both pro-inflammatory and pro-tumorigenic effects 35,36 .”
Chen, Y., Zhang, Q., Xie, W., Gao, P., Hu, Z., Wu, S., Bi, Z., Zhang, H., Gao, Y., Wang, C., et al. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114711 · Cited by 4
Zhang, X., Zhang, S., & Han, Y. (2025) · Cell Division · doi:10.1186/s13008-025-00164-y · Cited by 5
“Within the TME, macrophages are key immune cells involved in tumor immune evasion, progression, and response to treatment [11, 12].”
Zhang, Y., Xu, X., Li, S., Liao, C., Yang, X., & Zhang, W. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1660754 · Cited by 6
Wang, X., Shi, W., Xiao, Y., Wang, H., Si, H., Kang, Y., Si, J., Liu, Y., Li, S., & Jin, J. (2025) · Lung Cancer · doi:10.1016/j.lungcan.2025.108817 · Cited by 6
Qiao, Q., Guo, L., & Ma, Z. (2025) · Cytotechnology · doi:10.1007/s10616-025-00869-6 · Cited by 5
“TAMs typically differentiate into M1 and M2 phenotypes with anti-inflammatory/pro-tumor functions or pro-inflammatory/anti-tumor functions, respectively (Boutilier and Elsawa 2021).”
Zhang, J., Zhao, Y., Wang, X., Miao, C., Xu, W., Wan, C., Hu, B., & Qian, F. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s562182 · Cited by 4
“37 Instead, PD-L1 expression is primarily driven by pro-inflammatory signals such as the JAK/STAT and NF-κB pathways.”
Liang, X., Li, Y., Cai, J., Luo, L., Yang, P., Chen, Y., Zhou, J., Zeng, Y., Yu, J., Zhang, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202513257 · Cited by 6
Zhao, Q.-Y., & Wei, S.-J. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i12.113524 · Cited by 5
When Clocks Go Rogue: Circadian Rhythms and the Rise of Cancer
Robinson, A. S., Bennett, S. E., & Sato, S. (2026) · Journal of Biological Rhythms · doi:10.1177/07487304251391270 · Cited by 5
“Signals from the local microenvironment, such as those present in chronic inflammatory conditions or within the TME, can drive macrophages to adopt an immunosuppressive phenotype (Gao et al., 2022; Boutilier and Elsawa, 2021).”
Role of tumor microenvironment in regulator of tumor progression and immunotherapy
周平平 (2026) · Discover Oncology · doi:10.1007/s12672-026-04421-6 · Cited by 5
“On the other hand, M2 macrophages are associated with pro-tumor effects [24].”
Pörschke, J., Heidemann, S., Nehring, H. P., Lluch, A., Szymanski, W. G., Finkernagel, F., Preußer, C., Bhagwat, A. M., Stamm, T. J., Sommerfeld, L., et al. (2026) · Molecular Medicine · doi:10.1186/s10020-025-01416-x · Cited by 6
“Additionally, anti-tumor functions have also been typically attributed to them (Boutilier and Elsawa 2021).”
InfluentialLiu, Y., Wang, F., Deng, Y., Hu, Y., Shu, F., Jie, Y., Gou, G., Wen, M., Luo, C., Lu, X., et al. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5763 · Cited by 4
“…which collectively inhibit tumor growth (65,66). conversely, M2‑polarized macrophages secrete anti‑inflammatory cytokines such as IL‑4, IL‑10 and IL‑13, which are key for tumor progression, metastasis and angiogenesis, forming an essential component of the pro‑tumorigenic microenvironment (73,74).”
Targeting Inflammation and Immune Regulation in Chronic Inflammation Associated Cancers
Rabiu, L., Chinn, M., Chen, F., Yerkinkazhina, Y., Tian, Y., & Zhu, W. (2026) · Cancer Science · doi:10.1111/cas.70360 · Cited by 9
T cell fate regulation in EBV‑associated nasopharyngeal carcinoma (Review)
Zhang, L., Ding, S., Chen, D., Cai, B., & Mu, Z. (2026) · Oncology Reports · doi:10.3892/or.2026.9111 · Cited by 4
“As the tumor progresses, this balance often shifts toward the M2 phenotype, thereby facilitating immune evasion and accelerating tumor develop‑ ment (133).”
Zhao, C.-L., Zhang, Y., Guo, J.-K., Wang, J., Wang, C.-Y., Song, Z., & You, Y. (2026) · Autoimmunity · doi:10.1080/08916934.2026.2649582 · Cited by 5
Engineering Oncolytic Virus‐Armed Macrophages for Enhanced Cancer Immunotherapy
Wang, J., Lu, N., Yan, Z., Ye, L., Bai, L., Yuan, S., Zhu, Y., Xiong, Y., Bai, Y., Chen, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.75406 · Cited by 7
Li, C., Wang, S., Ma, X., Wang, T., Lu, R., Jia, X., Leng, Z., Kong, X., Zhang, J., & Li, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109729 · Cited by 9
Extended Opioid Exposure Modulates the Molecular Metabolism of Clear Cell Renal Cell Carcinoma
Garige, M., Poncet, S., Norris, A. L., Chou, C., Wu, W. W., Shen, R., Greenberg, J. W., Krane, L. S., & Sourbier, C. (2023) · Life · doi:10.3390/life13051196 · Cited by 4
Mao, C., & Xu, N. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230824093312 · Cited by 5
Sakti, S. P., Sari, F. N., Rachmawati, F., Widyarti, S., Rahayu, S., Soewondo, A., Jatmiko, Y. D., & Rifa’i, M. (2024) · Journal of Tropical Life Science · doi:10.11594/jtls.14.01.03 · Cited by 4
Immunological landscape of solid cancer: Interplay between tumor and autoimmunity
Singh, A. K., Duddempudi, P. K., Kenchappa, D., Srivastava, N., & Amdare, N. P. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.04.002 · Cited by 4
Huang, H., Zhong, P., Li, P., Peng, S.-J., Ding, X., Cai, X.-L., Chen, J., Zhu, X., Lu, Z., Tao, X.-Y., et al. (2024) · Current Medical Science · doi:10.1007/s11596-024-2886-y · Cited by 4
Pei, Q., Li, Z., Zhao, J., Zhang, H., Qin, T., & Zhao, J. (2024) · BMC Biotechnology · doi:10.1186/s12896-024-00879-w · Cited by 4
“M2 macrophage is tumour-resistant and immuno-suppressive [15], and the study of the role of M2 macrophages in cancer has been recognised in a large number of articles. miRNA-induced polarisation of M2 macrophages promotes metastasis in colorectal cancer [16].”
BackgroundLi, P., Su, G., & Cui, Y. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01454-5 · Cited by 6
“Recent studies indicate that the M1/M2 statuses defined in vitro may not accurately reflect the true in vivo conditions [9].”
BackgroundYe, Z., Zhang, Y., Xu, J., Li, K., Zhang, J., Ivanova, D., Zhang, X., Liao, S., Duan, L., Li, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179235 · Cited by 5
Wang, R., Liu, J., Jiang, B., Gao, B., Luo, H., Yang, F., Ye, Y., Chen, Z., Liu, H. S., Cui, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1454833 · Cited by 6
Luo, J., Tao, H., Chen, L., Hu, H., Mao, L., & Guan, H. (2025) · Carcinogenesis · doi:10.1093/carcin/bgaf009 · Cited by 4
Hu, F., Gong, W., Song, B., & Zhang, S. (2025) · The FASEB Journal · doi:10.1096/fj.202402757rr · Cited by 4
“26 In recent years, different voices successively came out about the paradigm of M1/M2 macrophages.”
Guardians of the Lung: The Multifaceted Roles of Macrophages in Cancer and Infectious Disease
Liu, Z., Ou, Y., He, X., Yuan, T., Li, M., Long, Y., Li, Y., & Tan, Y. (2025) · DNA and Cell Biology · doi:10.1089/dna.2024.0211 · Cited by 4
“Following activation, M2 macrophages secrete various anti-in fl ammatory factors further accelerate tumor microenvironment (TME) remodeling and promote the survival, growth, and metastasis of tumors through multiple mechanisms (Goswami et al., 2021; Boutilier and Elsawa, 2021).”
Stabile, R., Tucci, F. A., Verhagen, M. P., Embregts, C. W. E., van den Bosch, T. P. P., Joosten, R., Herdt, M. J. D., van der Steen, B., Nigg, A. L., Koljenović, S., et al. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf065 · Cited by 4
Bai, T., Li, P., Liu, Y., Cai, B., Li, G., Wang, W., Yan, R., Zheng, X., & Du, S. (2025) · European Journal of Histochemistry · doi:10.4081/ejh.2025.4178 · Cited by 4
“16 It has been shown that in the presence of interferon (IFN)- γ and lipopolysaccharide (LPS), TAMs polarize to M1 type, whereas upon exposure to interleukin (IL)-13 and IL-4, TAMs polarize to M2-type.”
Metadata
- Authors
- Boutilier, A. J., & Elsawa, S. F.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- Elsawa, Sherine F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 6995
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8268869
- OpenAlex
- W3173665490
- Cited by
- 1,631
- References
- 148
- Citations by year
- 2026: 281 · 2025: 409 · 2024: 429 · 2023: 359 · 2022: 144 · 2021: 9
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P20 GM113131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- macrophage polarization, tumor-associated macrophages, tumor microenvironment, tumor progression, angiogenesis, lymphangiogenesis, immunosuppression, hypoxia, metastasis, macrophage recruitment
- MeSH terms
- Tumor-Associated Macrophages, Animals, Hypoxia, Cell Transformation, Neoplastic, Humans, Inflammation, Macrophage Activation, Neoplasm Metastasis, Neoplasm Staging, Signal Transduction, Biomarkers, Immunophenotyping, Cytokines, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.